The second year of pandemic in the Arctic: examining spatiotemporal dynamics of the COVID-19 “Delta wave” in Arctic regions in 2021북극 팬데믹 2년차: 2021년 북극 지역의 COVID-19 "델타파" 시공간 역학 조사Article Published on 2022-12-012022-09-11 Journal: International journal of circumpolar health [Category] 변종, [키워드] Alaska Analysis approach Arctic Arctic region Canada case fatality ratio CFR Community COVID-19 COVID-19 pandemic death Delta Delta wave epidemiological examined Greenland Iceland inconsistency increase in indigenous knowledge Isolation lesson Measures National Northern Norway outbreak outcomes pandemic Pandemics public health prevention Research Resilience Russia second wave spatiotemporal Superstorm Tsunami vaccination rates variant vulnerability Wave Waves. [DOI] 10.1080/22423982.2022.2109562 PMC 바로가기 [Article Type] Article
Building-level wastewater surveillance of SARS-CoV-2 is associated with transmission and variant trends in a university settingArticle Published on 2022-12-012022-11-16 Journal: Environmental research [Category] COVID19(2023년), SARS, 변종, [키워드] Alpha variant analyzed associations Building-level surveillance Clinical data clinical testing collected complement Concentration contributed COVID-19 COVID-19 case creating Epidemiology genetic mutation hotspot identify include indicate Intervention Isolation less log N1 and N2 Nucleocapsid gene positive positive control quantification quarantine repeated reported Research SARS-CoV-2 SARS-CoV-2 RNA second wave South spring statistical significance statistically significant Surveillance Transmission university variant variants of concern Viral RNA Viral transmission VOCs Wastewater-based epidemiology. [DOI] 10.1016/j.envres.2022.114277 PMC 바로가기
High levels of soluble RAGE are associated with a greater risk of mortality in COVID-19 patients treated with dexamethasoneArticle Published on 2022-11-052022-11-15 Journal: Respiratory Research [Category] SARS, 바이오마커, [키워드] Admission association Biomarker Biomarkers Blood level Clinical management Control correlated covariates COVID-19 COVID-19 patient COVID-19 patients death Determination Dexamethasone died disease severity elevated Follow-up greater host inflammatory response IL-6 increased risk independent Infection Inflammation investigated Mortality NEWS2 Patient patient population patients patients treated Pearson positive positive individual predict prognostic RAGE receptor reduce risk SARS-CoV-2 score second wave significantly lower sRAGE. subject Teaching treated Treatment university [DOI] 10.1186/s12931-022-02220-5 PMC 바로가기
Comparison of maternal and neonatal outcomes of COVID-19 before and after SARS-CoV-2 omicron emergence in maternity facilities in Malawi (MATSurvey): data from a national maternal surveillance platformArticle Published on 2022-11-012022-11-16 Journal: The Lancet. Global health [Category] SARS, 변종, [키워드] Abstract adjusted age breath Clinical features COVID-19 death demographic demographic characteristics died enrolment event Fisher foundation health-care less Logistic regression material Maternal Melinda Gate National Neonatal Neonate Odds ratio outcome pandemic Patient platform Pregnancy pregnant pregnant patients reported SARS-CoV-2 SARS-COV-2 infection second wave Stillbirth sub-Saharan Africa Surveillance Symptom symptomatic symptoms of COVID-19 the SARS-CoV-2 translation Wellcome Trust [DOI] 10.1016/S2214-109X(22)00359-X PMC 바로가기
A scenario modelling analysis to anticipate the impact of COVID-19 vaccination in adolescents and children on disease outcomes in the Netherlands, summer 2021Article Published on 2022-11-012022-11-16 Journal: Eurosurveillance [Category] SARS, 변종, [키워드] Admissions age Analysis approach assist average booster dose children Children and adolescents COVID-19 COVID-19 vaccination COVID-19 vaccine death disease disease outcomes European future infection Government groups Health Health policy hospital incidence individual infections intensive care Mathematical modelling measure Netherland Netherlands occur Older age omicron onward transmission outcome reduction reductions in SARS-CoV-2 scenario modelling. second wave SEIR vaccination variant [DOI] 10.2807/1560-7917.ES.2022.27.44.2101090 PMC 바로가기
Comparative epidemiology of five waves of COVID-19 in Mexico, March 2020-August 2022Article Published on 2022-10-312022-11-16 Journal: BMC Infectious Diseases [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] 95% CI age analyzed Antigen association average calculated Care case fatality rates Comorbidities Comparative confirmed case confirmed cases COVID-19 COVID-19 case Critical death declined decrease Demographic factors Epidemic epidemic wave epidemiological Epidemiology estimates Factors Fatality rate FIVE Gender Health highest hospital Hospital admission Hospitalization hospitalizations Hospitalized In-hospital In-hospital death in-hospital mortality incidence increase in individual Intubated intubation intubations laboratory-confirmed male Metrics notable omicron pandemic Patient patients with comorbidities recorded reduction in Regression model risk SARS-CoV-2 SARS-CoV-2. second wave security severe disease severity subsequent Surveillance symptoms onset System vaccination variant were recorded [DOI] 10.1186/s12879-022-07800-w PMC 바로가기
Arylcoumarin perturbs SARS-CoV-2 pathogenesis by targeting the S-protein/ACE2 interactionArticle Published on 2022-10-112022-11-16 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 변종, [키워드] ACE2 adaptive Analysis antibody binding affinity binding site convalescent coumarin COVID-19 D614G death derivative develop docking drug human Angiotensin-converting enzyme human host in vitro in vivo Infection inhibitor inhibitors Interaction lack molecular molecular docking analysis Mutation N501Y new SARS-CoV-2 NF1 oxygen protein complex protocol rapid increase receptor Reinfection required S-protein SARS-CoV-2 SARS-CoV-2 pathogenesis SARS-CoV-2 spike glycoprotein second wave Spike proteins Treatment vaccinated individuals vaccination variant variants viral genome [DOI] 10.1038/s41598-022-20759-7 PMC 바로가기
Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, IndiaArticle Published on 2022-10-062022-11-15 Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI affecting age all age groups Antenatal anti-Nucleocapsid IgG Anti-spike anti-spike antibody antibodies antibody assigned attribute blood sample Cluster collected Community Comorbidity conducted Coverage COVID-19 cross-sectional cross-sectional survey cumulative death Epidemiology fatality female gender General population healthcare healthcare personnel household IgG IgG antibodies IgM IgM antibodies immunological India indicate Infection Kashmir less Logistic regression Logistic regression analysis occurred Odds ratio pandemic participant positive processed questionnaire reported SARS-CoV-2 second wave selected Sensitivity and specificity seropositive Seroprevalence seroprevalence. significantly Testing the SARS-CoV-2 transferred vaccination variable venous was collected was done women [DOI] 10.3389/fpubh.2022.967447 PMC 바로가기
Detecting and mitigating simultaneous waves of COVID-19 infectionsArticle Published on 2022-10-062022-11-15 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] Affect Analysis B.1.617.2 Can can be used catch caused country COVID-19 COVID-19 infection Data analysis Delta detect diffusion disease early stage Epidemic epidemiological geographical region growth healthcare Healthcare system Hypothesis identify India Infection International recommendation resource respond reveal second wave Shock Spread spread of COVID-19 Stage super-spreader event super-spreader events Support the disease the epidemic the SARS-CoV-2 virus the United State Travel variant [DOI] 10.1038/s41598-022-20224-5 PMC 바로가기
Vaccine hesitancy for coronavirus SARS-CoV-2 in Varanasi IndiaArticle Published on 2022-10-052022-11-15 Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 변종, 치료기술, 치료제, [키워드] age association conducted coronavirus coronavirus SARS-CoV-2 COVID-19 creating detect Factor Factors Frequency Gender Government Government of India help India medium MOST North North India overcome participated proportion Region reported SARS-CoV-2 second wave vaccinate vaccination Vaccine Vaccine hesitancy vaccine hesitancy. Varanasi variant variants virus [DOI] 10.3389/fpubh.2022.892584 PMC 바로가기